Answers are grounded in this paper and cite their sources.
Newly synthesized compounds have been found to inhibit mitochondrial monoamine oxidase (MAO) in mouse brain and rat liver. A series of 2‐acylamino‐3‐ tert ‐aminopropiophenones acted preferentially against MAO type B (2‐phenylethylamine as substrate), apparently irreversibly. 2‐Decanoylamino‐3‐morpholinopropiophenone acted similarly in vivo toward the cerebral MAO, producing a dose‐related inhibition. At high dose levels, MAO type A was also severely inhibited. The effects were produced rapidly and restoration of enzyme activity also appeared rapidly. The half‐life for MAO type A could be estimated from the rate of enzyme reappearance to be 13 h. It is suggested that the amino ketones undergo a β‐elimination reaction at the enzyme's active site, forming a reactive species (an α,β‐unsaturated ketone), which reacts covalently with a nucleophilic group of the enzyme by a Michael addition. Some other related compounds, derivatives of phenylpropane, also showed inhibitory activity against MAO, particularly against type A (serotonin as substrate). The morpholino compound might have promise as a quickly effective, short‐acting inhibitor of MAO type B.
No takes yet. Share an insight, caveat, or question.
Vunnam et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: